Shockwave Therapy as First-Line Treatment for Peyronie’s Disease: A Prospective Study - (A. SKOLARIKOS, M.D., ALARGOF, M.D., RIGAS, M.D., DELIVELIOTIS, M.D. and E. KONSTANTINIDIS, M.D)
Extracorporeal shock wave therapy (ESWT) in urology:a systematic review of outcome in Peyronie’s disease, erectile
dysfunction and chronic pelvic pain - (Grzegorz Lukasz Fojeck · Stefan Tiessen · Palle Jörn Sloth Osther 2017) - The objective was to evaluate high-level evidence studies of extracorporeal shock wave therapy (ESWT) for urological disorders. More...
Minimally invasive treatment of Peyronie's disease: evidence-based progress - (Department of Urology, Eastern Virginia Medical School, Norfolk, VA, *Division of Urologic Surgery, University of North Carolina, Chapel Hill, NC, and †Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA) - Peyronie’s disease (PD) is often physically and psychologically devastating for patients, and the goal of treatment is to improve symptoms and sexual function without adding
treatment-related morbidity. More..
Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial